Breaking News

05/02/2018

VACCINATED TO PREVENT CANCER accinated to prevent cancer    RESEARCHERS HAVE BEEN SUCCESSFUL ON RATS

New Delhi, February 5 (way2newstv.in):
This is definitely a good news for patients with leukemia cancer. Because the researchers have expressed hope that the epidemic can be restricted to vaccines. Chemotherapy and radiation therapy are available as a means of treatment for this disease. These treatments that are distressed can not be completely cured.





VACCINATED TO PREVENT CANCER accinated to prevent cancer    RESEARCHERS HAVE BEEN SUCCESSFUL ON RATS  

However, researchers and medical experts at Stanford University say that this disease can be checked with an effective vaccine that is not easily readily suffered. They say that a compound they produce can be destroyed by any form of cancer in the form of vaccine. Moreover, the vaccine can break the other cancerous substances in the body.They said it was first successfully launched on rats. The experiment was successful and they said it would soon be possible to experiment with human beings. The vaccine was made with both chemicals. When the vaccine was launched on rats, the researchers revealed that the two chemicals involved in its immune system were contributing to its body response. They also said that the cancer cells in other areas were also destroyed as well as the vaccine site.
In this way, the experiment on rats has succeeded, and it is possible to launch people in the soon-to-be. Basically ... they said that this vaccine will be used on 15 lymphoma patients. They also expressed hope that positive results could come. Researchers say that this vaccine was applied on 90 mice containing lymphoma problem, 87 of which were relieved of cancer.

The other three mice with the second phase therapy have also emerged from the cancerous demon. Professor Ronald Levi, an oncology professor who participated in the study said that this new vaccination procedure is primarily a reflection of a specific immune system to fight cancer cells.

No comments:

Post a Comment